A*STAR Bioprocessing Technology Institute (A*STAR BTI)

A*STAR scientists have found a way to boost the activity of neutrophils, a subset of immune cells, against disease-causing fungi.

If cell-based therapies are to make it to the clinic, methods to grow stem cells in vast quantities will need to be developed. Here’s how A*STAR scientists are tackling the challenge of manufacturing stem cells at scale.

Disruption of the methionine cycle in tumor-initiating cells disarms their tumorigenic capabilities, researchers say.

Cancer cells evade Taxol-induced cell death by downregulating the expression of a protein known as BimEL.

When parts of a bacteria’s cell wall enter into circulation, its host experiences more severe autoimmune reactions.

An antibody that targets a protein on the surface of stem cells also targets the same protein on some cancer cells

The key to efficient production of heart muscle from pluripotent stem cells lies in optimizing the density and replicative state of the starting material

A deeper understanding of chromosome capping could improve therapies for both cancer and aging

Leveraging the power of CRISPR-Cas9 to awaken antibiotics from their silent gene clusters

With
an eye to transfusion for patients, researchers are getting close to growing huge
numbers of red blood cells in industrial-grade vats

Excess fluid
surrounding the lungs in some lung cancer patients has a unique lipid
profile, which could help diagnose and treat the disease

A new antibody could hold the secret to making stem cell therapy safer